Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 184 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: No Conditions Clear all

Conditions: No Disease or Condition is Being Studied, Evaluating a Brief Intervention, Does Virtual Reality Aid in Hazmat Training
Interventions: Classroom Training, Virtual Reality Training; Behavioral
Lead sponsor: MetaMedia Training International, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Frederick, Maryland

Conditions: Healthy, no Evidence of Disease, Obesity
Interventions: behavioral dietary intervention, telephone-based intervention, laboratory biomarker analysis; Behavioral · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Asthma
Interventions: Apieron Insight eNO monitor; Device
Lead sponsor: Apieron; Industry
Eligibility: 12 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 12
States / cities: Mission Viejo, California • San Jose, California • Glastonbury, Connecticut + 9 more

Conditions: Surgical Wound Infection
Interventions: Next Science, Standard of Care; Device · Other
Lead sponsor: Next Science TM; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Birmingham, Alabama • Columbus, Georgia

Conditions: Eating Disorder, Type 1 Diabetes
Interventions: Not listed
Lead sponsor: HealthPartners Institute; Other
Eligibility: Not listed
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Liver Transplantation, Ischemia/Reperfusion Injury, Oxidative Injury
Interventions: Nitric Oxide; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 69 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Healthy, Physiology
Interventions: Definity, Exercise, Kidney Ultrasound; Drug · Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 50 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Progressive Multiple Sclerosis
Interventions: Light therapy; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Arrhythmia
Interventions: Virtual Reality (VR); Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Vasovagal Syncope, Postural Tachycardia Syndrome
Interventions: Phenylephrine, L-Ng-monomethyl Arginine (L-NMMA); Drug
Lead sponsor: New York Medical College; Other
Eligibility: 14 Years to 29 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2022
U.S. locations: 1
States / cities: Hawthorne, New York

Conditions: No Specific Medical Conditions or Disease States
Interventions: Telemetry monitoring; Device
Lead sponsor: Turtle Shell Technologies Pvt. Ltd.; Industry
Eligibility: 22 Years to 100 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Lake Jackson, Texas

Conditions: Hormone Receptor Positive Breast Cancer
Interventions: faslodex 500mg, arimidex 1mg, faslodex dummy, arimidex dummy; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years · Female only
Enrollment: 462 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2026
U.S. locations: 12
States / cities: Modesto, California • Savannah, Georgia • Auburn, Maine + 9 more

Conditions: Ventral Hernia, Incisional Hernia
Interventions: Mesh placement with Transfascial Sutures; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 325 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Survivorship, Recurrent, Recurrence, Cancer, Remission
Interventions: Exercise; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 70,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 3
States / cities: Los Angeles, California • New York, New York

Conditions: Thrombotic Thrombocytopenic Purpura (TTP)
Interventions: TAK-755; Biological
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 12
States / cities: Gainesville, Florida • Boston, Massachusetts • Minneapolis, Minnesota + 7 more

Conditions: Infection, Bacterial Infection, Sepsis
Interventions: Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor; Device
Lead sponsor: Brahms AG; Industry
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 3
States / cities: St Louis, Missouri • Camden, New Jersey • Providence, Rhode Island

Conditions: Pancreatic Head Neoplasm, Delayed Gastric Emptying, Post Operative Ileus, Whipple Procedure
Interventions: pancreaticoduodenectomy; Procedure
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Urolithiasis, Stones, Kidney, Renal Stones, Kidney Stones
Interventions: Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System, Standard Ureteroscopy (URS); Device
Lead sponsor: Calyxo, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 6
States / cities: Birmingham, Alabama • Gainesville, Florida • New York, New York + 3 more

Conditions: No Specific Medical Conditions or Disease States
Interventions: Telemetry and manual monitoring vs Contactless monitoring devices; Device
Lead sponsor: Turtle Shell Technologies Pvt. Ltd.; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Shreveport, Louisiana

Conditions: No Disease or Condition is Being Directly Studied, The Focus of the Study in Healthy Volunteers
Interventions: Osteopathic manipulation, Sham; Other
Lead sponsor: Lake Erie College of Osteopathic Medicine; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Erie, Pennsylvania

Conditions: Respiratory Tract Diseases
Interventions: Ointment containing camphor, eucalyptus oil, and menthol, Petroleum jelly; Other
Lead sponsor: Penn State University; Other
Eligibility: 2 Years to 11 Years
Enrollment: 143 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Major Depressive Disorder, Low Mood
Interventions: positive feedback; Behavioral
Lead sponsor: Bard College; Other
Eligibility: 18 Years to 34 Years
Enrollment: 171 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Annandale-on-Hudson, New York

Conditions: No Conditions for This Study. All Male Patients 18 Years of Age or Older Were Administered the LUTS, MSHQ, and Patient Demographics Questionnaire
Interventions: Not listed
Lead sponsor: Mid Michigan Health Centers; Other
Eligibility: 18 Years and older · Male only
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Jackson, Michigan

Conditions: Healthy
Interventions: fluoxetine HCL 40 mg capsules; Drug
Lead sponsor: Ranbaxy Laboratories Limited; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003
U.S. locations: 1
States / cities: Saint Charles, Missouri

Search by objective public record fields.

Evaluation of Virtual Reality in Hazmat Training

Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants

Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO)

Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial Fractures

Characteristics of Persons With an Eating Disorder and Type 1 Diabetes

Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation

Assessment of the Changes in Cortical and Medullary Renal Blood Flow During Exercise in Healthy Subjects Using Contrast Enhanced Ultrasound

Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis

Virtual Reality to Reduce Intra-procedural Anxiety and Sedation Needs During Procedures

Mechanisms of Vasovagal Syncope

Dozee Validation for Contactless Heart Rate and Respiration Monitoring in Clinical Settings

A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.

Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation

Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors

A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection

Nasogastric Decompression Following Pancreaticoduodenectomy

Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology

Pilot Clinical Evaluation of Dozee VS, a Contactless Continuous Vital Parameters Monitoring System in Hospital Patients

Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations

Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough

Positive Feedback vs. No-Feedback Games for Behavioral Change

Identification and Treatment of Men With BPH in the Primary Care Setting

Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions